December 5th, 2008
Podcast 22: Interview with Aaron Kesselheim about his meta-analysis of the efficacy of proprietary versus generic cardiovascular drugs.
Podcast: Play in new window | Download
Subscribe: RSS
This week, in addition to the usual news roundup, we talk with Dr. Aaron Kesselheim about his JAMA paper on the equivalence between proprietary and generic cardiovascular drugs. The data and the editorials are often at odds on this question.
Have a listen, and if you want to react to any of this, call 1-617-440-4374.
Links for this issue:
–Vitamin D
American Academy of Dermatology guidelines
Physician’s First Watch coverage
–Controlling hypertension
Journal Watch Cardiology coverage
Physician’s First Watch coverage
— Work hours for residents
Institute of Medicine recommendations
Physician’s First Watch coverage
–Depression in stable coronary disease
Journal Watch Cardiology coverage
–Generic versus proprietary cardiovascular drugs